نتایج جستجو برای: pravastatin

تعداد نتایج: 1688  

Journal: :The Journal of pharmacology and experimental therapeutics 2007
Muhammad R Marwali Chang-Ping Hu Bhavna Mohandas Abhijit Dandapat Prabhakar Deonikar Jiawei Chen Ian Cawich Tatsuya Sawamura Mahendra Kavdia Jawahar L Mehta

Lectin-like oxidized low-density lipoprotein (LDL) receptor-1 (LOX-1), a receptor for oxidized-LDL, is up-regulated in activated endothelial cells, and it plays a role in atherothrombosis. However, its role in platelet aggregation is unclear. Both aspirin and HMG CoA reductase inhibitors (statins) reduce LOX-1 expression in endothelial cells. In this study, we investigated the effect of aspirin...

Journal: :Circulation 1999
J F Plehn B R Davis F M Sacks J L Rouleau M A Pfeffer V Bernstein T E Cuddy L A Moyé L B Piller J Rutherford L M Simpson E Braunwald

BACKGROUND The role of lipid modification in stroke prevention is controversial, although increasing evidence suggests that HMG-CoA reductase inhibition may reduce cerebrovascular events in patients with prevalent coronary artery disease. METHODS AND RESULTS To test the hypothesis that cholesterol reduction with pravastatin may reduce stroke incidence after myocardial infarction, we followed ...

2017
Ahmed El-Olemy

Objectives: This study aimed to develop simple UV spectrophotometric methods for simultaneous determination of pravastatin sodium and pioglitazone hydrochloride without previous separation. Methods. The first method is the first derivative, where the peak amplitudes of first derivative of absorption spectra were measured at 249.7 and 277 nm for pravastatin sodium and pioglitazone hydrochloride ...

Journal: :Acta medica 2009
Alice Walder Pierre Baumann

We report on a serious side effect in a severely depressed 55-year-old woman, who presented an erythematous pigmented skin rash on the whole body under combination treatment with antidepressants, atypical antipsychotic drugs, the mood stabilizer lithium and the lipid-lowering drug pravastatin. The skin rash effect was most probably due, in first line, to olanzapine, but the cutaneous skin condi...

Journal: :American Journal of Obstetrics and Gynecology 2022

Pravastatin reduce pro-inflammatory mediators in feto-maternal interface (FMi) tissues and minimize PE-like symptoms vitro animal models. Several questions remain regarding the drug’s pharmacokinetics (PK), metabolism, efficacy that cannot be fully answered using traditional 2D cell culture or placental perfusion models prior to clinical trials. We used two distinct microfluidic organ-on-chip (...

Journal: :Circulation journal : official journal of the Japanese Circulation Society 2012
Kotaro Nochioka Shin-ichi Tanaka Masanobu Miura Do E Zhulanqiqige Yoshihiro Fukumoto Nobuyuki Shiba Hiroaki Shimokawa

BACKGROUND Ezetimibe is an inhibitor of cholesterol absorption in the intestine. We examined whether ezetimibe improves endothelial function, and if so, what mechanisms are involved. METHODS AND RESULTS Nineteen healthy subjects (male/female 14/5; mean age, 31±3 [SD] years-old) were randomized to receive ezetimibe (10mg/day) or pravastatin (10mg/day) for 4 weeks in a cross-over manner with a ...

Journal: :American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2001
M K Ito J C Lin A P Morreale D B Marcus R Shabetai T R Dresselhaus R R Henry

The effects of a pravastatin-to-simvastatin conversion program on low-density-lipoprotein (LDL) cholesterol levels were studied. Patients receiving pravastatin at a Veterans Affairs medical center were switched to simvastatin beginning in 1997. The dosage of simvastatin was based on the additional percent reduction in LDL cholesterol needed to achieve the goal specified by the National Choleste...

Journal: :Cardiovascular research 2009
Kimio Satoh Yoshihiro Fukumoto Makoto Nakano Koichiro Sugimura Jun Nawata Jun Demachi Akihiko Karibe Yutaka Kagaya Naoto Ishii Kazuo Sugamura Hiroaki Shimokawa

AIMS Mobilization of stem cells/progenitors is regulated by the interaction between stromal cell-derived factor-1 (SDF-1) and its ligand, CXC chemokine receptor 4 (CXCR4). Statins have been suggested to ameliorate pulmonary arterial hypertension (PAH); however, the mechanisms involved, especially their effects on progenitors, are largely unknown. Therefore, we examined whether pravastatin ameli...

Journal: :Arteriosclerosis and thrombosis : a journal of vascular biology 1994
G Franceschini M Cassinotti G Vecchio G Gianfranceschi F Pazzucconi T Murakami M Sirtori A L D'Acquarica C R Sirtori

Familial combined hyperlipidemia (FCHL) is the most common genetic lipid disorder among young survivors of myocardial infarction. Elevations of plasma total and low-density lipoprotein (LDL) cholesterol and the prevalence of small, dense LDL particles are both involved in the high coronary risk of FCHL patients. We investigated the ability of pravastatin to favorably correct plasma lipid and li...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید